Drug intelligence / Profile preview

PRX-Plus

Development stage
Unknown
Lead developer
WiQo
Modality
Hydrogel Systems → Drug Delivery Systems, Transdermal Patches → Device-based Delivery → Drug Delivery Systems
Administration
Topical
01

Overview

PRX-Plus is a non-invasive, needle-free topical skin biorevitalizer developed by the Italian company WiQo and distributed in India by Emcutix Biopharmaceuticals. The formulation is a droplet-based topical treatment designed for aesthetic dermatology, specifically targeting skin tightening, rejuvenation, and the improvement of skin texture. It utilizes a patented combination of trichloroacetic acid (TCA), hydrogen peroxide (H2O2), and kojic acid. This combination allows the TCA to penetrate the deeper layers of the dermis to stimulate collagen production and growth factors while the hydrogen peroxide mitigates the caustic effects on the epidermis, preventing peeling or downtime. It is suitable for all skin types and provides immediate lifting and brightening effects.

Brand names
PRX-Plus
Other names
PRX-T33PRX-T-33PRX-T 33
02

Targets

TYR (Tyrosinase)

Beyond the preview

Go deeper on PRX-Plus.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on PRX-Plus.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call